High burden of Carbapenem-resistant Enterobacterales: A prospective cross-sectional study at a tertiary hospital in Morocco - 19/11/26
, Echchakery Mohamed a
, Ben Houmich Taoufik b, c
, Dilagui Ilham b, c
, Lamrani Hanchi Asmae b, c
, Soraa Nabila b, c 
Abstract |
Objectives |
The present study aimed to determine and update the prevalence of Carbapenem-resistant Enterobacterales , to characterize carbapenemase production, and to assess antimicrobial susceptibility in a Moroccan tertiary hospital.
Patients and methods |
A prospective cross-sectional study was conducted from January 2021 to December 2022, during which time 6672 Enterobacteriaceae isolates were recovered from clinical specimens from patients with suspected bacterial infections. Species were identified using MALDI-TOF-MS and the BD Phoenix® M50 for antimicrobial susceptibility according to EUCAST screening criteria. NG-Test® CARBA 5 assay was used for carbapenemase detection and characterization.
Results |
Among the 6672 Enterobacteriaceae isolates, 1289 showed decreased susceptibility to ertapenem (19.3%). Klebsiella pneumoniae was the predominant species (47.4%), followed by Enterobacter cloacae complex (20.8%). The neonatal intensive care unit was the main reservoir of cases (22.0%). Blood and purulent specimens were the most frequent sources of isolation (62.8% combined). Among the 322 non-duplicate isolates tested, 252 (78.3%) were carbapenemase producers. Antibiotic susceptibility profile displayed high rates of resistance to ciprofloxacin (91.0%), gentamicin (85.1%), and cotrimoxazole (86.6%). NDM (34.8%) and OXA-48-like (30.1%) were the predominant enzymes. NDM and OXA-48-like co-production was observed in 12.1% of isolates. A novel VIM + OXA-48-like combination was detected in an Enterobacter cloacae complex isolate.
Conclusions |
This study demonstrates an alarming increase in the proportion of Enterobacterales exhibiting decreased susceptibility to carbapenems, highlighting a need for robust infection prevention measures, rapid diagnostics, and continuous epidemiological surveillance in high-dependency units.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Carbapenem-resistant Enterobacterales prevalence nearly doubled (10.1% to 19.3%). |
• | The neonatal intensive care unit was the primary reservoir of cases. |
• | Metallo-beta-lactamases and oxacillinases were the predominant carbapenems. |
• | This is the first local report of Enterobacter cloacae complex co-producing VIM and OXA-48-like enzymes. |
• | Resistance mechanisms in the hospital are increasingly diversified. |
Keywords : Carbapenem resistance, Carbapenemase, Enterobacterales, Morocco, NDM
Plan
Vol 56 - N° 8
Article 105372- novembre 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
